EVGN Latest Press Releases

-- October 26, 2026 --

Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain PRNewswire 8:00 AM

-- October 20, 2026 --

Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL PRNewswire 8:00 AM

-- October 6, 2026 --

Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors PRNewswire 4:00 PM

-- September 30, 2026 --

Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance PRNewswire 7:15 AM

-- August 31, 2026 --

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward PRNewswire 8:00 AM

-- August 25, 2026 --

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees PRNewswire 7:01 AM

-- August 18, 2026 --

Evogene Reports Second Quarter and First Half 2026 Financial Results PRNewswire 8:05 AM

-- August 14, 2026 --

Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation PRNewswire 7:01 AM

-- July 30, 2026 --

Evogene Schedules Second Quarter 2026 Financial Results Release PRNewswire 7:00 AM

-- July 22, 2026 --

Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases PRNewswire 8:00 AM

-- July 15, 2026 --

AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag Capabilities PRNewswire 7:30 AM

-- July 8, 2026 --

Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery PRNewswire 7:01 AM

-- June 24, 2026 --

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization PRNewswire 8:00 AM

-- June 9, 2026 --

Evogene to Present Its Pharma Division Achievements at the BIO International Convention PRNewswire 7:00 AM

-- June 2, 2026 --

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica PRNewswire 7:00 AM

Market Data Delayed 15 Minutes